DBD vs BL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

DBD

50.4
AI Score
VS
DBD Wins

BL

47.8
AI Score

Investment Advisor Scores

DBD

50score
Recommendation
HOLD

BL

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric DBD BL Winner
Revenue 1.82B 183.16M DBD
Net Income 20.50M 8.13M DBD
Gross Margin 24.8% 76.0% BL
Net Margin 1.1% 4.4% BL
Operating Income 90.00M 6.24M DBD
ROE 2.1% 2.7% BL
ROA 0.5% 0.6% BL
Total Assets 3.74B 1.46B DBD
Current Ratio 1.27 1.70 BL

Relative Price Performance (Last 90 Days)

DBD 1M: -11.7% · 3M: -4.2% BL 1M: +6.6% · 3M: +0.5%

Current Technical Phase

DBD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 33

RSI (14): 32.9 · Price: $73.59

BL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 58.0 · Price: $31.40

Fundamentals Snapshot

Metric DBD BL
Market Cap
Forward P/E 10.5 11.3
Trailing P/E 24.9 76.7
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.3% 0.8%
Operating Margin 0.1% 0.0%
EPS 2.86 0.40
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, DBD is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.